Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Poly(A) binding protein cytoplasmic 1 pseudogene 11 (PABPC1P11) is classified as a pseudogene, sharing sequence similarity with the functional PABPC1 gene but lacking a protein-coding function. PABPC1P11 does not produce a functional protein, has no confirmed biological activity, and is not considered a target for therapeutic intervention. While its parent gene PABPC1 is involved in mRNA stability and translation by binding poly(A) tails, PABPC1P11 itself has no such role[2]. Clarification: - If you seek information about the *functional protein*, refer to **Poly(A) binding protein cytoplasmic 1 (PABPC1)**[4][1][3][5]. - If you have questions about alternative pseudogenes (like PABPC1P1, PABPC1P2, etc.), please specify. For **structured information purposes**: treat *PABPC1P11* as a *non-target pseudogene*, not as a functional receptor, enzyme, or other druggable entity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Poly(A) binding protein cytoplasmic 1 pseudogene 11 (PABPC1P11).